BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7646515)

  • 1. Design of noncovalent trypsin inhibitor based on the X-ray crystal structure of the complex.
    Nakamura M; Tomoo K; Ishida T; Taguchi H; Tsuda Y; Okada Y; Okunomiya A; Wanaka K; Okamoto S
    Biochem Biophys Res Commun; 1995 Aug; 213(2):583-7. PubMed ID: 7646515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray and neutron protein crystallographic analysis of the trypsin-BPTI complex.
    Kawamura K; Yamada T; Kurihara K; Tamada T; Kuroki R; Tanaka I; Takahashi H; Niimura N
    Acta Crystallogr D Biol Crystallogr; 2011 Feb; 67(Pt 2):140-8. PubMed ID: 21245536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
    Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of specific structures using alpha,beta-dehydro-phenylalanine residues: synthesis, crystal structure, and molecular conformation of Boc-L-Val-delta Phe-delta Phe-L-Val-delta Phe-delta Phe-L-Val-OCH3, a 3(10)-helical heptapeptide.
    Mitra SN; Dey S; Karthikeyan S; Singh TP
    Biopolymers; 1997 Jan; 41(1):97-105. PubMed ID: 8986122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
    Sherawat M; Kaur P; Perbandt M; Betzel C; Slusarchyk WA; Bisacchi GS; Chang C; Jacobson BL; Einspahr HM; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):500-7. PubMed ID: 17372355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crystal structures of the complexes between bovine beta-trypsin and ten P1 variants of BPTI.
    Helland R; Otlewski J; Sundheim O; Dadlez M; Smalås AO
    J Mol Biol; 1999 Apr; 287(5):923-42. PubMed ID: 10222201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A.
    McGrath ME; Mirzadegan T; Schmidt BF
    Biochemistry; 1997 Nov; 36(47):14318-24. PubMed ID: 9400368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
    Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
    Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
    Sperl S; Bergner A; Stürzebecher J; Magdolen V; Bode W; Moroder L
    Biol Chem; 2000 Apr; 381(4):321-9. PubMed ID: 10839461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the anticarcinogenic Bowman-Birk inhibitor from snail medic (Medicago scutellata) seeds complexed with bovine trypsin.
    Capaldi S; Perduca M; Faggion B; Carrizo ME; Tava A; Ragona L; Monaco HL
    J Struct Biol; 2007 Apr; 158(1):71-9. PubMed ID: 17142058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
    Huang K; Lu W; Anderson S; Laskowski M; James MN
    Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates.
    Toyota E; Ng KK; Sekizaki H; Itoh K; Tanizawa K; James MN
    J Mol Biol; 2001 Jan; 305(3):471-9. PubMed ID: 11152605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
    Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD
    Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two crystal structures of the leupeptin-trypsin complex.
    Kurinov IV; Harrison RW
    Protein Sci; 1996 Apr; 5(4):752-8. PubMed ID: 8845765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.